Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors

被引：0
|
作者：
Gallois, Claire
Landi, Matteo
Taieb, Julien
Lonardi, Sara
Bergamo, Francesca
Intini, Rossana
Maddalena, Giulia
Pietrantonio, Filippo
Corti, Francesca
Ambrosini, Margherita
Martinetti, Antonia
Germani, Marco Maria
Boccaccio, Chiara
Vetere, Guglielmo
Mouillet-Richard, Sophie
de Reynies, Aurelien
Puig, Pierre Laurent
Cremolini, Chiara
机构：
[1] Univ Paris Cite, Inst Canc Paris CARPEM, Digest Oncol Dept, Hop Europeen G Pompiduo, Paris, France
[2] Univ Pisa, Pisa, Italy
[3] Univ Paris, Dept Gastroenterol & Gastrointestinal Oncol, Hop Europeen Georges Pompidou, AP HP, Paris, France
[4] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Padua, Italy
[5] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Med Oncol 1, Padua, Italy
[6] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Med Oncol 1, Padua, Italy
[7] Ist Oncol Veneto IOV IRCCS, Oncol Unit 1, Padua, Italy
[8] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
[9] IRCCS Fdn Natl Canc Inst, Milan, Italy
[10] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[11] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
[12] Univ Paris Cite, Sorbonne Univ, Ctr Rech Cordeliers, INSERM, Paris, France
[13] Inst Canc Paris CARPEM, Dept Biol, Hop Europeen Georges Pompidou, APHP Ctr, Paris, France
[14] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[15] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3570
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment Efficacy of Immune Checkpoint Inhibitors for Patients with Advanced or Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Pyo, Junhee
    Park, Hyo-Jung
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [42] Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer
    Bess, Shelby N.
    Greening, Gage J.
    Muldoon, Timothy J.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 49 : 1 - 9
  • [43] Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment
    Hong, Ji Hyung
    Woo, In Sook
    CANCER LETTERS, 2023, 565
  • [44] Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors-2020 Update
    Jung, Gerhard
    Benitez-Ribas, Daniel
    Sanchez, Ariadna
    Balaguer, Francesc
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 14
  • [45] Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis
    Kotoula, Vassiliki
    Fostira, Florentia
    Fountzilas, Elena
    JAMA ONCOLOGY, 2019, 5 (05) : 740 - 741
  • [46] Landscape of immune-checkpoint inhibitors for metastatic colorectal cancer: A meta-analysis
    Shek, D.
    Carlino, M. S.
    Nagrial, A.
    Moujaber, T.
    Read, S. A.
    Gao, B.
    Ahlenstiel, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1410 - S1410
  • [47] Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes
    Shek, Dmitrii
    Akhuba, Liia
    Carlino, Matteo S.
    Nagrial, Adnan
    Moujaber, Tania
    Read, Scott A.
    Gao, Bo
    Ahlenstiel, Golo
    CANCERS, 2021, 13 (17)
  • [48] Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177
    Yoshino, Takayuki
    Kim, Tae Won
    Yong, Wei Peng
    Shiu, Kai-Keen
    Jensen, Benny Vittrup
    Jensen, Lars Henrik
    Smith, Denis
    Garcia-Carbonero, Rocio
    Alcaide-Garcia, Julia
    Gibbs, Peter
    De la Fouchardiere, Christelle
    Rivera, Fernando
    Elez, Elena
    Bendell, Johanna
    Le, Dung T.
    Yang, Ping
    Farooqui, Mohammed
    Marinello, Patricia
    Diaz, Luis A.
    Andre, Thierry
    ANNALS OF ONCOLOGY, 2021, 32 : S284 - S284
  • [49] Evaluation of complete pathological remission rates in surgically resected MSI-high metastatic colorectal cancers (mCRC).
    Ludford, Kaysia
    Cohen, Romain
    Foo, Wai Chin
    Thomas, Jane V.
    Parc, Yann
    Svrcek, Magali
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Neutrophil-Lymphocyte Ratio Confers Prognostic Significance in MSI-high Colorectal Cancer
    Clarke, C. N.
    Rodriguez-Bigas, M. A.
    Chang, G.
    Bednarski, B.
    Messick, A.
    Feig, B.
    Nguyen, S.
    Cuddy, A.
    Skibber, J. M.
    You, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S17 - S18
12345